ML26058A214

20260227 1102 NRC 2026 Charter

ML26058A214
Person / Time
Issue date:	02/27/2026
From:	NRC/SECY
To:
References
Download: ML26058A214 (0)

Text

UNITED STATES NUCLEAR REGULATORY COMMISSION CHARTER FOR THE ADVISORY COMMITTEE ON THE MEDICAL USES OF ISOTOPES

1. Advisory Committees Official Designation:

Advisory Committee on the Medical Uses of Isotopes (the Committee or ACMUI).

2. Authority:

The Committee is established pursuant to Section 161(a) of the Atomic Energy Act of 1954, as amended, (42 U.S.C § 2201(a)) as an NRC discretionary committee in accordance with the Federal Advisory Committee Act (FACA), as amended, (5 U.S.C.

§ 1001 et. seq).

3. Objectives and Scope of Activities:

The Committee provides advice, as requested by the Director, Division of Materials Safety, Security, State, and Tribal Programs (MSST), Office of Nuclear Material Safety and Safeguards (NMSS), on policy and technical issues that arise in the regulation of the medical uses of radioactive material.

4. Description of Duties:

As requested by the Director, MSST in NMSS, the Committee comments on changes to relevant NRC regulations and guidance; evaluates certain non-routine uses of radioactive material; provides technical assistance in licensing, inspection, and enforcement cases; and brings key issues to the attention of the agency for appropriate action. The Committee members may also serve as medical consultants to the Director, MSST, as requested.

5. Agency or Federal Officer Receiving the Advisory Committees Advice/Recommendations:

Director, Division of Materials Safety, Security, State, and Tribal Programs Office of Nuclear Material Safety and Safeguards U.S. Nuclear Regulatory Commission Washington, DC 20555

6. Support:

Office of Nuclear Material Safety and Safeguards U.S. Nuclear Regulatory Commission Washington, DC 20555

7. Estimated Annual Operating Costs and Staff Years:

a. Federal Personnel: $366,000 for 1.0 FTE.

b. Proposed Payments to Members and Number of Members: $70.000 for 13 members.

c. Reimbursable Costs: $19,000.

8. Designated Federal Officer (DFO):

The Chairman of the NRC (or designee) shall designate a Federal officer or a full-or part-time NRC employee as the Designated Federal Officer (DFO). The DFO for ACMUI will:

a.

Ensure that ACMUI activities comply with FACA, the governmentwide FACA regulations at 41 C.F.R. Part 102-3, NRC administrative procedures (including the NRCs FACA regulations at 10 C.F.R. Part 7), and any other applicable laws and regulations;

b.

Approve or call all ACMUI committee and subcommittee meetings;

c.

Approve the agenda;

d.

Attend all ACMUI committee and subcommittee meetings for their duration;

e.

Fulfill the requirements under § 10(b) of FACA (codified at 5 U.S.C. 1009(b));

f.

Adjourn any meeting when the DFO determines it to be in the public interest;

g.

Chair any meeting when so directed by the Commission of the NRC;

h.

Maintain information on ACMUI activities and provide such information to the public, as applicable; and

i.

Ensure ACMUI committee members and subcommittee members, as applicable, receive the appropriate training (e.g., FACA overview, ethics training) for efficient operation and compliance with FACA and the FACA implementing regulations (41 C.F.R. Part 102-3, as amended).

The DFO should ensure a public facing website that complies with 41 C.F.R. § 102-3.120(b) is created and maintained for the ACMUI.

9. Estimated Number and Frequency of Meetings:

Approximately six meetings per year, four of which are web conferences, with video and telephone capabilities.

10. Duration:

Continuing Committee.

11. Termination:

Unless renewed by appropriate action, the Committee will terminate two years from the date this charter is filed.

12. Membership and Designation:

With the exception of one regular Government employee representing the U.S. Food and Drug Administration, members are appointed by the Director, NMSS as Special Government Employees. The Committee consists of 13 members, including health care professionals in diverse specialties who represent diagnostic and therapeutic applications of medicine, medical administration, and patient care advocacy, and an Agreement State representative.

13. Subcommittees:

The Committee does not have standing subcommittees. The full Committee may create ad hoc subcommittees that report to the full Committee. All work prepared by subcommittees is reviewed and approved by the full committee. Subcommittees will not provide advice or work products directly to the agency or any other Federal officer.

14. Recordkeeping:

The Committee records will be handled in accordance with General Records Schedule 6.2 and approved NRC records disposition schedules. These records shall be available for public inspection and copying, subject to the Freedom of Information Act, 5 U.S.C.

552.

15. Filing date:

February 27, 2026 Russell E. Chazell Federal Advisory Committee Management Officer Office of the Secretary